Ocular Oncology News

Patients who provide tissue for a uveal melanoma gene test will have the option of having a sample of the tumor stored for up to 5 years so that it can be used in potential future developments related to the disease, according to a news release from Castle Biosciences.

HAMBURG — Proton beam irradiation has been a major breakthrough in the treatment of uveal melanoma, overcoming several limitations of previous systems and providing  tumor control over 10 years in 98% of cases, a speaker said here.

Patients with lacrimal gland adenoid cystic carcinoma may be treated with neoadjuvant intra-arterial cytoreductive chemotherapy instead of conventional treatment for improved survival, according to a study.

In vivo OCT imaging had a positive association with postoperative histology of periocular basal cell carcinoma of the eyelids, according to a study.

A 71-year-old woman presented to the New England Eye Center Oculoplastics Department for a right upper lid lesion that was present for approximately 1 year. She said that it did not change in appearance or size and was tender to touch. The lesion did not reduce in size despite weeks of warm compresses. Her medical history included diabetes type 2, gout, cardiac murmur, hypertension, hyperlipidemia and hypothyroidism, all of which were being treated with medications.

Early diagnosis and multifaceted treatment are important for the long-term survival rate of children with retinoblastoma, according to a study.

A treatment algorithm of medication, laser hyaloidotomy, and vitrectomy or transscleral cyclophotocoagulation was successful in managing malignant glaucoma, according to a study.

Iris nevus showed a low risk of advancing to melanoma, according to a study, and a mnemonic guide can be used to remember factors that may predict growth.

Eyes undergoing ophthalmic artery chemosurgery for hereditary retinoblastoma had fewer new tumors after radiation or systemic chemotherapy than previously believed, according to a study.

Eyes undergoing ophthalmic artery chemosurgery for hereditary retinoblastoma had fewer new tumors after radiation or systemic chemotherapy than previously believed, according to a study.